Vinkristine bağlı nöropati iyileşmesinde pridostigmin ve pridoksin umut verici tedavi seçeneğidir. (Turk J Ophthalmol 2014; 44: 330-1)
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Vinkristine bağlı bilateral ptosis ve ekstarnal oftalmopleji gelişen akut lenfoblastik lösemili vakada başarılı pridoksin ve pridostigmin tedavisini sunmayı amaçladık.
📊
Temel Bulgular & Veri:Vinkristine bağlı bilateral ptosis ve ekstarnal oftalmopleji gelişen akut lenfoblastik lösemili vakada başarılı pridoksin ve pridostigmin tedavisini sunmayı amaçladık.
💡
Sonuç & Katkı:Vinkristine bağlı nöropati iyileşmesinde pridostigmin ve pridoksin umut verici tedavi seçeneğidir. (Turk J Ophthalmol 2014; 44: 330-1)
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri
Özet
Vinkristine bağlı bilateral ptosis ve ekstarnal oftalmopleji gelişen akut lenfoblastik lösemili vakada başarılı pridoksin ve pridostigmin tedavisini sunmayı amaçladık. Vinkristine bağlı nöropati iyileşmesinde pridostigmin ve pridoksin umut verici tedavi seçeneğidir. (Turk J Ophthalmol 2014; 44: 330-1)
Abstract
Summary In this manuscript, we present the case of a patient with acute lymphoblastic leukemia who developed vincristine-induced bilateral ptosis and external ophthalmoplegia and who was treated successfully with pyridoxine and pyridostigmine. Pyridostigmine and pyridoxine are promising treatment option in cases of vincristine-induced neuropathy. (Turk J Ophthalmol 2014; 44: 330-1)
🔖
Bu Makaleye Atıf Yap
KIVANÇ, S. A., ALTUN, A., OLCAYSU, O. O., OLCAYSU, E., KESKİN, Z. Y. (2022). Effectiveness of pyridoxine and pyridostigmine in the treatment of vincristine-ınduced bilateral ptosis and external ophthalmoplegia: A Case Report. Türk Oftalmoloji Dergisi, Cilt: 44 - Sayı: 4, 330–331. https://ajindex.com/articles/638029
Rowinsky EK, Donehower RC. The clinical pharmacology and useantimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther. 1991;52:35-84.
Dixit G, Dhingra A, Kaushal D. Vincristine induced cranial neuropathy.Assoc Physicians India. 2012;60:56-8.
Bay A, Yilmaz C, Yilmaz N, Oner AF. Vincristine induced cranial polyneuropathy. Indian J Pediatr. 2006;73:531-3.
Jaggi AS, Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology. 2012;291:1-9. Chan JD. Pharmacokinetic drug interactions of vinca alkaloids: summarycase reports. Pharmacotherapy. 1998;18:1304-7.
Reinders-Messelink HA, Van Weerden TW, Fock JM, et al. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukemia. European J Paed Neurol. 2000;4:225-33.
Jeng MR, Feusner J. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2001;18:137-42.
Gursel O, Sari E, Altun D, Atay AA, Akin R. Vincristine-Induced unilateral ptosis in a child. Pediatr Neurol. 2009;41:461-3.
Batta B, Trechot F, George JL, Angioi K. Vincristine-induced unilateral ptosis. Acta Ophthalmologica. 2012;90:249. Müller L, Kramm CM, Tenenbaum T, Wessalowski R, Göbel U. Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine. Pediatr Blood Cancer. 2004;42:287-88.
Dejan S, Dragana B, Ivana P, Borivoje B, Marko P. Vincristine induced unilateral ptosis. J Pediatr Hematol Oncol. 2009;3:463.